Bruker (NASDAQ:BRKR) Shares Gap Down to $63.54

Bruker Co. (NASDAQ:BRKR)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $63.54, but opened at $58.75. Bruker shares last traded at $66.85, with a volume of 312,445 shares.

Analyst Ratings Changes

BRKR has been the topic of several recent analyst reports. Stifel Nicolaus reduced their target price on Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. The Goldman Sachs Group cut their price target on Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, July 9th. Citigroup decreased their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. StockNews.com lowered shares of Bruker from a “buy” rating to a “hold” rating in a research report on Tuesday, May 21st. Finally, Bank of America lowered their price target on shares of Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a report on Monday, May 20th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $81.78.

Bruker Price Performance

The company’s 50-day simple moving average is $64.86 and its 200-day simple moving average is $75.92. The stock has a market capitalization of $9.15 billion, a P/E ratio of 23.11, a price-to-earnings-growth ratio of 2.39 and a beta of 1.20. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.81 and a quick ratio of 0.91.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 17th. Investors of record on Monday, June 3rd were paid a $0.05 dividend. The ex-dividend date of this dividend was Monday, June 3rd. This represents a $0.20 annualized dividend and a yield of 0.32%. Bruker’s dividend payout ratio (DPR) is currently 7.27%.

Institutional Trading of Bruker

A number of hedge funds have recently made changes to their positions in the business. First Horizon Advisors Inc. lifted its holdings in Bruker by 120.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 218 shares during the last quarter. Lindbrook Capital LLC boosted its holdings in shares of Bruker by 68.2% during the 4th quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock worth $26,000 after buying an additional 146 shares during the period. Rise Advisors LLC acquired a new position in Bruker in the 1st quarter valued at about $27,000. Neo Ivy Capital Management bought a new position in Bruker in the 4th quarter valued at about $30,000. Finally, GAMMA Investing LLC acquired a new stake in Bruker during the fourth quarter worth approximately $33,000. 79.52% of the stock is owned by institutional investors and hedge funds.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.